Effects of Diet Changes on Metabolism
キーワード
概要
説明
Some people appear to be more resistant than others to gaining weight when they overeat, though they do not increase their physical activity. This may indicate that adaptive mechanisms exist, which lead to wasting as heat part of the excess calories taken in. Such mechanisms exist in rodents including activation of brown fat, a tissue which can also convert calories to heat for warmth. Human studies have provided conflicting results. A pilot study on the relationship of the weight change over time with the changes in the amount of energy an individual uses over 24 hours (energy expenditure, EE) with 48-h overfeeding (OF) and fasting (F) in Pima Indian men has shown that persons with the greatest increase in EE with OF and the smallest decrease in EE with F gained the least weight over time, indicating that the ability to waste more calories when overfed may reduce weight gain. Other studies, however, have not shown this relationship. In addition, it has been proposed that unbalanced diets can help magnify these effects. The aims of this study are to test whether (a) the changes in EE in response to 24-h OF and F predict changes in weight over two years, and (b) high-carbohydrate diets or diets with high or low protein amounts may magnify the metabolic response to 24-h OF compared to normal protein and high-fat diets. 64 volunteers will be evaluated at baseline, 6 months and on a yearly basis for up to 7 years. At baseline, subjects will undergo 8 24-h sessions in a human respiratory chamber to measure EE while on a weight-maintaining diet, and then in random order: fasting, 200% OF on a normal-protein diet, 200% OF on a high fat, low-protein diet, 200% OF on a high-fat, normal-protein diet, 200% OF on a high fat, high protein diet, and 200% OF on a high-carbohydrate, normal-protein diet. Fifteen volunteers will have two additional chambers to try and understand if the source of carbohydrates, i.e. simple sugars versus complex carbohydrates, in a high carbohydrate diet affect metabolism. Thirty volunteers will also undergo 2 positron emission tomography (PET) studies to look at the relationship of brown fat with EE in adult humans. Body weight and composition will be measured at each subsequent admission. Hormonal measurements to find determinants of adaptive changes in EE in response to OF and F will also be performed. This study will provide significant insights into possible mechanisms that may help people resist weight gain and obesity.
日付
| 最終確認済み: | 09/27/2020 |
| 最初に提出された: | 08/29/2007 |
| 提出された推定登録数: | 08/29/2007 |
| 最初の投稿: | 08/30/2007 |
| 最終更新が送信されました: | 10/28/2020 |
| 最終更新日: | 10/29/2020 |
| 実際の研究開始日: | 05/21/2008 |
状態または病気
段階
アームグループ
| 腕 | 介入/治療 |
|---|---|
| Healthy Volunteers with normal glucose regulation Healthy volunteers with normal glucose regulation |
適格基準
| 研究の対象となる年齢 | 18 Years に 18 Years |
| 研究に適格な性別 | All |
| サンプリング方法 | Probability Sample |
| 健康なボランティアを受け入れる | はい |
| 基準 | - Inclusion Criteria: - Age: 18-55 years, to exclude effects of aging on energy expenditure and weight change. For the PET-CT substudy, women will be limited to ages 18-40 years because there is a high likelihood that for women greater than 40 years, their personal physician may recommend an annual routine mammogram, thereby increasing their annual radiation exposure. Men will also be limited to this age range to prevent age discrepancies between men and women for this substudy. - Premenopausal - Weight: less than or equal to 450 lb (maximum weight allowed on the DXA scanning tables by the manufacturer). Exclusion Criteria - History or clinical manifestation of: - Current smoking - Impaired glucose tolerance (IGT), type 1 and type 2 diabetes - Endocrine disorders, such as Cushing s disease, pituitary disorders, and hypo- and hyperthyroidism - Pulmonary disorders, including chronic obstructive pulmonary disease, which would limit ability to follow the protocol (investigator judgment) - Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease - Hypertension, as diagnosed and treated by an outside physician or by sitting blood pressure measurement, using an appropriate cuff, higher than 140/90 mmHg on two or more occasions - Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 3 times normal - Renal disease, as defined by serum creatinine concentrations greater than or equal 1.5 mg/dl and/or proteinuria greater than 300 mg/day (200 (Micro)g/min) - Central nervous system disease, including previous history of cerebrovascular accidents, dementia, and neurodegenerative disorders - Cancer requiring treatment in the past five years, except for non-melanoma skin cancers or cancers that have clearly been cured or in the opinion of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer). - Infectious disease such as active tuberculosis, HIV (by self-report), chronic coccidiomycoses or other chronic infections that might influence weight. - Conditions not specifically mentioned above may serve as criteria for exclusion at the discretion of the investigators - Alcohol and/or drug abuse (more than 3 drinks per day and use of drugs, such as amphetamines, cocaine, heroin, or marijuana). - Pregnancy or lactation - For the PET-CT substudy, radiation exposure to the torso for research or medical purposes within the past 12 months - Positive Urinalysis Drug Screen Prior to beginning any of the study procedures, all subjects will be fully informed of the aim, nature, and risks of the study prior to giving written informed consent. The study s informed consent will be obtained by a principal or associate investigator, research physician or physician assistant working in the clinical research unit. |
結果
主な結果の測定
1. Weight, DXA scans [at baseline visit, 6 month visit, and then annually for up to 7 years]
2. Resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
3. Weight, DXA scans, resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
二次的な結果の測定
1. Resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
2. Hormone values in blood and urine [at baseline visit, 6 month visit, and then annually for up to 7 years]
3. Resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, FDG-PET and FDG- CT scans, core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
4. Resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
5. Core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
6. Resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, core body and distal skin temperature [at baseline visit, 6 month visit, and then annually for up to 7 years]
7. Resting metabolic rate, thermic effect of food, energy cost of physical activity, cycle ergometry, core body and distal skin temperature, questionnaires [at baseline visit, 6 month visit, and then annually for up to 7 years]
